Human endothelial stimulation of allogeneic T cells via a CTLA-4 independent pathway
- 31 December 1994
- journal article
- Published by Elsevier in Transplant Immunology
- Vol. 2 (4), 342-347
- https://doi.org/10.1016/0966-3274(94)90013-2
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Uncovering of Functional Alternative CTLA-4 Counter-Receptor in B7-Deficient MiceScience, 1993
- The proliferative response of human T cells to allogeneic IFN-γ-treated endothelial cells is mediated via both CD2/LFA-3 and LFA-1/ICAM-1 and -2 adhesion pathwaysTransplant Immunology, 1993
- T CELL SUBSET RESPONSES TO ALLOGENEIC ENDOTHELIUMTransplantation, 1993
- HUMAN CD4+ T CELLS PROLIFERATE TO HLA-DR+ ALLOGENEIC VASCULAR ENDOTHELIUMTransplantation, 1993
- The two-signal model of lymphocyte activation twenty-one years laterImmunology Today, 1992
- T-cell activation by the CD28 ligand B7 is required for cardiac allograft rejection in vivo.Proceedings of the National Academy of Sciences, 1992
- Long-Term Survival of Xenogeneic Pancreatic Islet Grafts Induced by CTLA4lgScience, 1992
- CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clonesNature, 1992
- CTLA-4 is a second receptor for the B cell activation antigen B7.The Journal of Experimental Medicine, 1991
- A Cell Culture Model for T Lymphocyte Clonal AnergyScience, 1990